Company: CERO
Filing Date: 2025-06-06
Form Type: 424B3
Source: 0001213900-25-052185
Chunk: 4

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-06-06
Form: 424B3
Chunk 4
---
 of employment (the “Kucharchuk Base Salary”).

Pursuant to the Kucharchuk Employment Agreement,
Mr. Kucharchuk is also eligible to earn a one time performance bonus, which will be 30% of the Kucharchuk Base Salary, less applicable
withholdings. Mr. Kucharchuk’s performance bonus will be based on the achievement of performance objectives determined by the Board,
subject to Mr. Kucharchuk’s continued employment with the Company through the date that such bonus is paid. The Kucharchuk Employment
Agreement also provides that Mr. Kucharchuk is eligible to participate in the benefit plans of the Company, if any, in accordance with
the terms of such plans in effect from time to time, including equity awards pursuant to the Plan. In addition, Mr. Kucharchuk will be
entitled to receive a monthly contribution of up to $1,750 from the Company toward his healthcare premiums. In connection with entry into
the Kucharchuk Employment Agreement, Mr. Kucharchuk has received certain equity awards under the Plan, the amount of such awards, vesting
schedule and performance criteria are as set forth in the Kucharchuk Employment Agreement.

<div align='center'>1</div>

The Kucharchuk Employment Agreement is for no
specific period of time and either Mr. Kucharchuk or the Company may terminate the employment at any time and for any reason or no reason,
with or without cause, and with or without notice.

The foregoing summaries of each of the Ehrlich
Employment Agreement and the Kucharchuk Employment Agreement contained in this Item 5.02 do not purport to be complete and are subject
to, and qualified in their entirety by, the full text of the Ehrlich Employment Agreement and the Kucharchuk Employment Agreement, copies
of which are attached hereto as Exhibits 10.1 and 10.2, respectively, and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

| Exhibit No. 
 10.1*+      
 10.2*+      |     | Description                                                                                                            
 Employment Agreement by and between CERo Therapeutics Holdings, Inc., and Chris Ehrlich, dated May 30, 2025            
 Employment Agreement by and between CERo Therapeutics Holdings, Inc., and Andrew Albert Kucharchuk, dated May 30,